Dow ends 900 points lower on concerns about new Covid vaccine-resistant variant, S&P 500 and Nasdaq too drops 2%
Dow ends 900 points lower on concerns about new Covid vaccine-resistant variant, S&P 500 and Nasdaq too drops 2%
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
FDA Reviewing Merck's COVID Pill For Emergency Authorization
Newsy
Watch VideoAn experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one..
Advertisement
More coverage
'Strong' Start To Kids Vaccine Campaign, But Challenges Loom
Newsy
Watch VideoThe campaign to vaccinate elementary school age children in the U.S. is off to a strong start, health officials said..